8-(3-Chlorostyryl)caffeine - CAS 147700-11-6
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
8-(3-Chlorostyryl)caffeine
Catalog Number:
147700-11-6
Synonyms:
(E)-8-[2-(3-Chlorophenyl)ethenyl]-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione; CSC
CAS Number:
147700-11-6
Description:
Selective A2A antagonist. Also MAO-B inhibitor
Molecular Weight:
330.77
Molecular Formula:
C16H15ClN4O2
Quantity:
Grams-Kilos
Quality Standard:
In-house
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC3=CC(=CC=C3)Cl.CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC3=CC(=CC=C3)Cl
InChI:
1S/2C16H15ClN4O2/c2*1-19-12(8-7-10-5-4-6-11(17)9-10)18-14-13(19)15(22)21(3)16(23)20(14)2/h2*4-9H,1-3H3/b2*8-7+
InChIKey:
YMUNFKYGBSLPLQ-ONYUMSKCSA-N
Targets:
Adenosine A2a
Chemical Structure
CAS 147700-11-6 8-(3-Chlorostyryl)caffeine

Related Adenosine A2a Products


CAS 913842-25-8 Lu AA 47070

Lu AA 47070
(CAS: 913842-25-8)

Prodrug of a potent and selective adenosine A2A receptor antagonist

CAS 634924-89-3 ANR 94

ANR 94
(CAS: 634924-89-3)

Adenosine A2A antagonist

CAS 870070-55-6 Tozadenant

Tozadenant
(CAS: 870070-55-6)

An orally administered, potent and selective inhibitor of the adenosine 2a (A2a) receptor

CAS 1061747-72-5 TC-G 1004

TC-G 1004
(CAS: 1061747-72-5)

Potent and selective A2A antagonist

CAS 316173-57-6 SCH 442416

SCH 442416
(CAS: 316173-57-6)

Very selective, high affinity A2A antagonist

CAS 155270-99-8 Istradefylline

Istradefylline
(CAS: 155270-99-8)

A very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM)

CAS 147700-11-6 8-(3-Chlorostyryl)caffeine

8-(3-Chlorostyryl)caffeine
(CAS: 147700-11-6)

Selective A2A antagonist. Also MAO-B inhibitor

CAS 54447-84-6 c-di-AMP

c-di-AMP
(CAS: 54447-84-6)

A2A inverse agonist; Also endogenous STING and DDX41 agonist

CAS 442908-10-3 Vipadenant

Vipadenant
(CAS: 442908-10-3)

Adenosine A2 receptor antagonists; Immunosuppressants

CAS 139180-30-6 ZM 241385

ZM 241385
(CAS: 139180-30-6)

Potent, highly selective A2A antagonist

SCH 58261
(CAS: 160098-96-4)

Potent, highly irreversible selective A2A antagonist

Reference Reading


1.Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.
Rivara S1, Piersanti G, Bartoccini F, Diamantini G, Pala D, Riccioni T, Stasi MA, Cabri W, Borsini F, Mor M, Tarzia G, Minetti P. J Med Chem. 2013 Feb 14;56(3):1247-61. doi: 10.1021/jm301686s. Epub 2013 Jan 16.
A systematic modification of the caffeinyl core and substituents of the reference compound (E)-8-(3-chlorostyryl)caffeine led to the 9-deazaxanthine derivative (E)-6-(4-chlorostyryl)-1,3,5,-trimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4-(3H,5H)-dione (17f), which acts as a dual human A(2a) antagonist/MAO-B inhibitor (K(i)(A(2A)) = 260 nM; IC(50)(MAO-B) = 200 nM; IC(50)(MAO-A) = 10 μM) and dose dependently counteracts haloperidol-induced catalepsy in mice from 30 mg/kg by the oral route. The compound is the best balanced A(2A) antagonist/MAO-B inhibitor reported to date, and it could be considered as a new lead in the field of anti-Parkinson's agents. A number of analogues of 17f were synthesized and qualitative SARs are discussed. Two analogues of 17f, namely 18b and 19a, inhibit MAO-B with IC(50) of 68 and 48 nM, respectively, being 5-7-fold more potent than the prototypical MAO-B inhibitor deprenyl (IC(50) = 334 nM).